Intellectual Property

Our IP Team, which has grown steadily since the 1990s, comprises some of Switzerland’s leading intellectual property law lawyers, covering all aspects of patent, know-how, trademark, copyright, design and unfair competition law. This includes clarifying the noninfringement of third-party rights, management of worldwide IP portfolios, exploitation and enforcement of intellectual property rights and defense against infringement allegations, both out of court and before state courts and arbitratral tribunals. Our well experienced team has the specialised expertise and human resources to help our Swiss and foreign clients succeed. We typically work in an international context. We follow the important legal, economic and technical developments in Switzerland and worldwide and often help shape them. Innovative companies, whether small, medium-sized or large, usually either have us on their side or as an opponent.

Our team offers you access to experts especially in these areas:

The multi-award-winning patent team at MLL combines outstanding skills in patent litigation with an exceptional understanding of the technical realities in fields such as the chemical and electrical engineering, life sciences and telecommunication industries.

More

Our team represents and advises international and Swiss clients in all fields of trademark and design law.

More

MLL’s long-standing and widely respected copyright and media team has specialised expertise concerning issues of copyright and media law in addition to in-depth knowledge of new media and related technologies.

More

The legal field of protected geographical indications has massively gained in significance in recent years.

More


“Excellent law firm, with outstanding partners and associates in all areas of IP. It is a pleasure working with them, my preferred choice in Switzerland”

Legal 500 EMEA, Intellectual Property, 2023

Related to this Practice Area

Publications

Swiss Federal Supreme Court confirms validity of Bristol-Myers Squibb’s SPC for apixaban

Bristol-Myers Squibb successfully defended the Swiss SPC for the pharmaceutical active ingredient apixaban, used in the blockbuster anticoagulant Eliquis.
  • EN

Die Nutzung fremder Marken zur Suchmaschinenoptimierung

4 | 2024 sic! Stiftung, Bern / Helbing Lichtenhahn Verlag, Basel
  • DE

Legal 500: Patent Litigation Comparative Guide

The Legal 500 Country Comparative Guides 2024, October 2024
  • EN

Value of a Photograph

Value of a Photograph Vortrag während INGRES Kongress, 02.07.2024
  • DE